scispace - formally typeset
J

Jacqueline Cordell

Researcher at University of Oxford

Publications -  25
Citations -  4821

Jacqueline Cordell is an academic researcher from University of Oxford. The author has contributed to research in topics: Monoclonal antibody & Antibody. The author has an hindex of 17, co-authored 24 publications receiving 4769 citations. Previous affiliations of Jacqueline Cordell include John Radcliffe Hospital & Royal College of Surgeons in Ireland.

Papers
More filters
Journal ArticleDOI

Detection of normal and chimeric nucleophosmin in human cells.

TL;DR: Three new monoclonal antibodies are described, two of which recognize, by Western blotting, the N-terminal portion of NPM present in the N PM-ALK fusion protein and also in two other NPM fusion proteins (NPM-RARalpha and NPM-MLF1).
Journal ArticleDOI

Preparation of peroxidase: antiperoxidase (PAP) complexes for immunohistological labeling of monoclonal antibodies.

TL;DR: Gel filtration revealed that monoclonal PAP is of lower molecular weight than conventional PAP complexes (fulfilling theoretical predictions based on the monospecificity of monOClonal antibodies), and gave the best immunohistological labeling reactions.
Journal ArticleDOI

CD5 is associated with the human B cell antigen receptor complex.

TL;DR: It is demonstrated that CD5 is associated with the B cell receptor (BCR) complex and serves as substrate for BCR‐induced tyrosine kinase activity, meaning CD5+ B cells have a unique potential to modulate BCR signals.
Journal Article

Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

TL;DR: An assay that is based upon a monoclonal antibody (ICR4) is described that enables the quantitation of cisplatin-induced adducts on DNA down to 3 nmol Pt/g DNA, the level necessary to produce toxic effects in cells in vitro and in vivo, using just a few micrograms of DNA.
Journal ArticleDOI

The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation.

TL;DR: Results suggest that the synthesis of B29 begins later in precursor B cells than that of mb‐1, and ceases before the terminal plasmacyte phase, indicating that this component in man is also encoded by the B29 gene.